Provided by Tiger Fintech (Singapore) Pte. Ltd.

Protalix BioTherapeutics

1.86
-0.5400-22.50%
Post-market: 1.870.0105+0.56%19:56 EDT
Volume:5.51M
Turnover:9.61M
Market Cap:148.30M
PE:24.02
High:1.90
Open:1.68
Low:1.60
Close:2.40
52wk High:3.10
52wk Low:1.01
Shares:79.73M
Float Shares:60.76M
Volume Ratio:6.67
T/O Rate:9.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0774
EPS(LYR):0.0404
ROE:15.99%
ROA:6.05%
PB:2.97
PE(LYR):46.01

Loading ...

Company Profile

Company Name:
Protalix BioTherapeutics
Exchange:
AMEX
Establishment Date:
- -
Employees:
213
Office Location:
2 University Plaza,Suite 100,Hackensack,New Jersey,United States
Zip Code:
07601
Fax:
- -
Introduction:
Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell-expressed recombinant PEGylated Uricase which is in Phase I trial for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate that is in preclinical phase for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. The company was incorporated in 1993 and is headquartered in Karmiel, Israel. Protalix BioTherapeutics, Inc. is a subsidiary of Protalix Ltd.

Directors

Name
Position
Dror Bashan
Director, President and Chief Executive Officer
Eliot Richard Forster
Chairman of the Board
Aharon Schwartz
Independent Director
Amos Bar Shalev
Independent Director
Gwen A. Melincoff
Independent Director
Pol F. Boudes
Independent Director
Shmuel Ben Zvi
Independent Director
Christian Elze
Director

Shareholders

Name
Position
Dror Bashan
Director, President and Chief Executive Officer
Gilad Mamlok
Senior Vice President and Chief Financial Officer
Yaron Naos
Senior Vice President, Operations